Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma

Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma - Evaluation of the clinical outcome and cost effectiveness of carbon ion radiotherapy or transarterial chemoembolization to localized hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036455

Enrollment

Registered

2019-04-10

Start date

2019-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with localized HCC treated with C-ion RT or TACE.

Exclusion criteria

Exclusion criteria: The patient with: 1) direct infiltration of the gastrointestinal tract; 2) intrahepatic metastasis; 3) distant metastasis, and; 4) major vascular invasion were excluded.

Design outcomes

Primary

Measure	Time frame
Overall survival rate Local control rate Cost effectiveness	—

Countries

Japan

Contacts

Public ContactShintaro Shiba

Gunma University Graduate School of Medicine Department of Radiation Oncology

shiba4885@yahoo.co.jp027-220-8383

Outcome results